Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis.

Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS.

Am J Obstet Gynecol. 2011 Jun;204(6):503.e1-12. doi: 10.1016/j.ajog.2011.02.020. Review.

2.

Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae.

Romero R, Kusanovic JP, Chaiworapongsa T, Hassan SS.

Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):313-27. doi: 10.1016/j.bpobgyn.2011.02.006. Review.

3.

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.

Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH.

Prenat Diagn. 2011 Jan;31(1):66-74. doi: 10.1002/pd.2660. Erratum in: Prenat Diagn. 2011 Aug;31(8):832.

PMID:
21210481
4.

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation.

Brosens I, Pijnenborg R, Vercruysse L, Romero R.

Am J Obstet Gynecol. 2011 Mar;204(3):193-201. doi: 10.1016/j.ajog.2010.08.009. Review.

5.

Hypertension induced by episodic reductions in uteroplacental blood flow in gravid rat.

Reho JJ, Peck J, Novak J, Ramirez RJ.

Hypertens Pregnancy. 2011;30(2):208-20. doi: 10.3109/10641955.2010.507853.

PMID:
20846047
6.

Genome profiles in maternal blood during early onset preeclampsia and towards term.

Dahlstrøm B, Esbensen Y, Vollan H, Oian P, Bukholm G.

J Perinat Med. 2010 Nov;38(6):601-8. doi: 10.1515/JPM.2010.095.

PMID:
20807010
7.

Are early and late preeclampsia distinct subclasses of the disease--what does the placenta reveal?

van der Merwe JL, Hall DR, Wright C, Schubert P, Grové D.

Hypertens Pregnancy. 2010;29(4):457-67. doi: 10.3109/10641950903572282.

PMID:
20701467
8.

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.

Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, Rey E.

Am J Obstet Gynecol. 2010 Oct;203(4):383.e1-8. doi: 10.1016/j.ajog.2010.06.014.

PMID:
20691410
9.

First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies.

Hafner E, Metzenbauer M, Stümpflen I, Waldhör T, Philipp K.

Placenta. 2010 Sep;31(9):756-63. doi: 10.1016/j.placenta.2010.06.011.

PMID:
20633928
10.

Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort.

Mongraw-Chaffin ML, Cirillo PM, Cohn BA.

Hypertension. 2010 Jul;56(1):166-71. doi: 10.1161/HYPERTENSIONAHA.110.150078.

11.

A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia.

Chaiworapongsa T, Romero R, Tarca AL, Kusanovic JP, Gotsch F, Mittal P, Kim SK, Vaisbuch E, Mazaki-Tovi S, Erez O, Dong Z, Kim CJ, Yeo L, Hassan SS.

Am J Obstet Gynecol. 2010 Jun;202(6):550.e1-10. doi: 10.1016/j.ajog.2010.04.002.

13.

Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

DiGiulio DB, Gervasi M, Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Seok KS, Gómez R, Mittal P, Gotsch F, Chaiworapongsa T, Oyarzún E, Kim CJ, Relman DA.

J Perinat Med. 2010 Sep;38(5):503-13. doi: 10.1515/JPM.2010.078.

14.

Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome.

Stekkinger E, Zandstra M, Peeters LL, Spaanderman ME.

Obstet Gynecol. 2009 Nov;114(5):1076-84. doi: 10.1097/AOG.0b013e3181b7b242.

PMID:
20168110
15.

Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate.

Mazaki-Tovi S, Vaisbuch E, Romero R, Kusanovic JP, Chaiworapongsa T, Kim SK, Nhan-Chang CL, Gomez R, Alpay Savasan Z, Madan I, Yoon BH, Yeo L, Mittal P, Ogge G, Gonzalez JM, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Oct;23(10):1119-28. doi: 10.3109/14767050903572190.

16.

Neurokinin B and pre-eclampsia: a decade of discovery.

Page NM.

Reprod Biol Endocrinol. 2010 Jan 14;8:4. doi: 10.1186/1477-7827-8-4. Review.

17.

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y.

BJOG. 2010 Feb;117(3):314-20. doi: 10.1111/j.1471-0528.2009.02453.x.

18.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

19.

Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Mazaki-Tovi S, Romero R, Kim SK, Vaisbuch E, Kusanovic JP, Erez O, Chaiworapongsa T, Gotsch F, Mittal P, Nhan-Chang CL, Than NG, Gomez R, Nien JK, Edwin SS, Pacora P, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2010 Aug;23(8):857-68. doi: 10.3109/14767050903301017.

20.

Ischemic placental disease: maternal versus fetal clinical presentations by gestational age.

Ananth CV, Smulian JC, Vintzileos AM.

J Matern Fetal Neonatal Med. 2010 Aug;23(8):887-93. doi: 10.3109/14767050903334885.

PMID:
19895356
Items per page

Supplemental Content

Support Center